Search research articles
Contact Us
Filters
Showing results (421-430 of 466) with videos related to
Page
of 47
Sort By:
The American Journal of Tropical Medicine and Hygiene
|
May 14, 2005
A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum
Laarni G Villahermosa, Tranquilino T Fajardo, Rodolfo M Abalos, et al.
The Journal of Clinical Investigation
|
February 2, 2021
Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia
Rose A Gubitosi-Klug, Barbara H Braffett, Susan Hitt, et al.
Diabetes/Metabolism Research and Reviews
|
September 23, 2009
Challenges in developing endpoints for type 1 diabetes intervention studies
Simona Cernea, Itamar Raz, Kevan C Herold, et al.
Synapse (New York, N.Y.)
|
May 21, 1998
Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters
A J Fischman, A A Bonab, J W Babich, et al.
Diabetes Care
|
February 20, 2014
Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes
Jay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
JAMA
|
June 11, 2014
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial
Mikael Knip, Hans K Åkerblom, Dorothy Becker, et al.
Diabetes
|
January 30, 2016
HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression
Alberto Pugliese, David Boulware, Liping Yu, et al.
Frontiers in Immunology
|
May 13, 2021
Islet Autoimmunity in Adults With Impaired Glucose Tolerance and Recently Diagnosed, Treatment Naïve Type 2 Diabetes in the Restoring Insulin SEcretion (RISE) Study
Barbara M Brooks-Worrell, Ashley H Tjaden, Sharon L Edelstein, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 6, 2010
Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity
E Ortqvist, B Brooks-Worrell, K Lynch, et al.
Diabetes
|
June 13, 2012
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data
Carla J Greenbaum, Craig A Beam, David Boulware, et al.
Page
of 47
Search research articles
Search
Showing results (421-430 of 466) with videos related to
Sort By:
Page
of 47
The American Journal of Tropical Medicine and Hygiene
|
May 14, 2005
A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum
Laarni G Villahermosa, Tranquilino T Fajardo, Rodolfo M Abalos, et al.
The Journal of Clinical Investigation
|
February 2, 2021
Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia
Rose A Gubitosi-Klug, Barbara H Braffett, Susan Hitt, et al.
Diabetes/Metabolism Research and Reviews
|
September 23, 2009
Challenges in developing endpoints for type 1 diabetes intervention studies
Simona Cernea, Itamar Raz, Kevan C Herold, et al.
Synapse (New York, N.Y.)
|
May 21, 1998
Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters
A J Fischman, A A Bonab, J W Babich, et al.
Diabetes Care
|
February 20, 2014
Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes
Jay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
JAMA
|
June 11, 2014
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial
Mikael Knip, Hans K Åkerblom, Dorothy Becker, et al.
Diabetes
|
January 30, 2016
HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression
Alberto Pugliese, David Boulware, Liping Yu, et al.
Frontiers in Immunology
|
May 13, 2021
Islet Autoimmunity in Adults With Impaired Glucose Tolerance and Recently Diagnosed, Treatment Naïve Type 2 Diabetes in the Restoring Insulin SEcretion (RISE) Study
Barbara M Brooks-Worrell, Ashley H Tjaden, Sharon L Edelstein, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 6, 2010
Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity
E Ortqvist, B Brooks-Worrell, K Lynch, et al.
Diabetes
|
June 13, 2012
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data
Carla J Greenbaum, Craig A Beam, David Boulware, et al.
Page
of 47